Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.
K. Schroeder,W. Tremaine,D. M. Ilstrup
1987 · DOI: 10.1056/NEJM198712243172603
New England Journal of Medicine · 2,823 Citations
TLDR
It is concluded that oral 5-ASA administered in a dosage of 4.8 g per day is effective therapy, at least in the short term, for mildly to moderately active ulcerative colitis.